NIM
ITCI
NXG Investment Management’s Intra-Cellular Therapies Inc. ITCI Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-13,248
| Closed | -$756K | – | 88 |
|
|
2022
Q2 | $756K | Sell |
13,248
-241
| -2% | -$13.8K | 0.08% | 57 |
|
|
2022
Q1 | $825K | Sell |
13,489
-79
| -0.6% | -$4.83K | 0.07% | 64 |
|
|
2021
Q4 | $710K | Buy |
13,568
+5,928
| +78% | +$310K | 0.07% | 80 |
|
|
2021
Q3 | $285K | Buy |
7,640
+70
| +0.9% | +$2.61K | 0.03% | 100 |
|
|
2021
Q2 | $309K | Sell |
7,570
-659
| -8% | -$26.9K | 0.03% | 96 |
|
|
2021
Q1 | $279K | Buy |
8,229
+1,856
| +29% | +$62.9K | 0.03% | 102 |
|
|
2020
Q4 | $203K | Buy |
+6,373
| New | +$203K | 0.02% | 114 |
|